Arrowhead Research said that it has appointed City of Hope researcher John Rossi to the scientific advisory board of subsidiary Calando Pharmaceuticals.
Rossi is one of Calando's co-founders. He also co-founded RNAi firm Dicerna Pharmaceuticals, and is a member of the SABs of Benitec and Kylin Therapeutics.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
